Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)

SHE:301126 Revenue

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd had revenue of 1.42B CNY in the quarter ending September 30, 2025, with 2.79% growth. This brings the company's revenue in the last twelve months to 5.38B, up 5.30% year-over-year. In the year 2024, Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd had annual revenue of 5.23B with 34.07% growth.

• Revenue (ttm): 5.38B
• Revenue Growth: +5.30%
• P/S Ratio: 0.48
• Revenue / Employee: 1.10M
• Employees: 4,887
• Market Cap: 2.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.23B	1.33B	34.07%
Dec 31, 2023	3.90B	611.18M	18.56%
Jan 1, 2023	3.29B	700.15M	27.01%
Dec 31, 2021	2.59B	252.41M	10.79%
Dec 31, 2020	2.34B	-116.76M	-4.75%